Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3845975

Cc1ccccc1N1CCN(c2ccnc3ccc(-c4c[nH]nc4C(F)(F)F)cc23)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1S P09871 1/20 0.41
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
PDGFRB P09619 4/20 0.37
HTR1A P08908 2/20 0.36
HTR1D P28221 2/20 0.36
HTR1B P28222 2/20 0.36
MTOR P42345 2/20 0.36
HTR2A P28223 1/20 0.36
HTR6 P50406 1/20 0.36
CYP3A4 P08684 4/20 0.36
SLC22A12 Q96S37 1/20 0.36
HPGD P15428 1/20 0.36
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
XBP1 P17861 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3844992 0.88 MAPKAPK2 (0.40) HTR6GAANCF1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL3848126 0.88 KCNH2 (0.44) C1SPDGFRBMTORNCF1ALDH1A1
Trifluoroacetic Acid SCHEMBL5852249 0.85 GAA (0.46) PDGFRBMTORGAAMAPTNCF1
Trifluoroacetic Acid SCHEMBL3857455 0.81 NR1H2 (0.37) HTR1AHTR1DHTR1BHTR2AHTR6
SCHEMBL3851844 0.81 CYP3A4 (0.50) CYP3A4HPGDNCF1ALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL3855245 0.81 MEN1 (0.42) PDGFRBMTORMAPTSMN1; SMN2NCF1
SCHEMBL3847156 0.79 AKR1C3 (0.43) PDGFRBMTORCYP3A4HPGDLMNA
SCHEMBL3847838 0.78 SORD (0.38) HTR1AHTR1DHTR1BMTORHTR2A
SCHEMBL3852542 0.78 GAA (0.51) MTORGAAMAPTNCF1KMT2A
SCHEMBL3853124 0.77 NR1H2 (0.42) HTR1AHTR1DHTR1BHTR2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed